De novo splice site mutation in the antithrombin III (AT3) gene causing recurrent venous thrombosis: demonstration of exon skipping by ectopic transcript analysis. 1992

L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
Charter Molecular Genetics Laboratory, Thrombosis Research Institute, London, United Kingdom.

A single basepair substitution at conserved position -1 in the exon 3a donor splice site of the liver-expressed antithrombin III (AT3) gene was detected by PCR/direct sequencing in a patient with sporadic type 1 ATIII deficiency and recurrent venous thrombosis. The lesion, a heterozygous silent AAG----AAA transition at Lys 176 occurred de novo in the proposita. Ectopic transcript analysis of lymphocyte mRNA demonstrated the presence of an abnormally sized mRNA specific to the patient which was shown by cDNA sequencing to lack exon 3a. Oligonucleotide discriminant hybridization demonstrated the absence of any detectable transcript of normal length derived from the disease allele. These findings demonstrate the utility of ectopic transcript analysis in the characterization of defects of mRNA splicing.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012326 RNA Splicing The ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm. RNA, Messenger, Splicing,Splicing, RNA,RNA Splicings,Splicings, RNA
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
October 1993, Blood,
L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
November 1994, Human genetics,
L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
April 2000, American journal of medical genetics,
L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
March 1992, Human genetics,
L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
December 1992, Human genetics,
L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
July 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
May 1993, Blood,
L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
January 1993, Human mutation,
L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
December 2001, Thrombosis research,
L P Berg, and C B Grundy, and F Thomas, and D S Millar, and P J Green, and R Slomski, and J Reiss, and V V Kakkar, and D N Cooper
August 2019, Brain research bulletin,
Copied contents to your clipboard!